Global Interventional Cardiology Devices Market Outlook, 2031
The Global Interventional Cardiology Devices Market is segmented By product(Angioplasty Stents, Catheters, Angioplasty Balloons, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Structural Heart Devices, Other Accessories); By Application(Coronary Interventions, Peripheral Vascular Interventions, Others); By End User(Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Others).
- Bonafide Research
- 02-03-2026
- Pages : 191
- Figures : 36
- Tables : 86
- Region : Global
- Category : Lifescience & Healthcare
- Medical Devices
The Global Interventional Cardiology Devices market was valued at more than USD 20.95 Billion in 2025, and expected to reach a market size of more than USD 30.79 Billion by 2031 wi
- Historical Period2020-2024
- Base Year2025
- Forecast Period2026-2031
- Market Size (2025) USD 20.95 Billion
- Market Size (2031) USD 30.79 Billion
- CAGR (2026-2031) 6.8%
- Largest MarketNorth America
- Fastest Market Asia-Pacific
- Format
Featured Companies
- 1. Johnson & Johnson,
- 2. Abbott Laboratories
- 3. Medtronic plc
- 4. Stryker corporation
- 5. Boston Scientific Corporation
- 6. B. Braun Melsungen AG
- 7. Terumo Corporation
- 8. Vapotherm Inc.
- 9. Dragerwerk AG & Co. KGaA
- More...
Market Analysis
The global interventional cardiology devices market is experiencing steady growth and is projected to expand significantly over the coming years. The market growth is driven by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and continuous advancements in technologies such as drug eluting stents and bioresorbable vascular scaffolds. In May 2025, Mentice secured a USD 642,000 order from a top 20 global MedTech company to expand its simulation-based training solutions for interventional cardiology. The order highlights the growing demand for advanced procedural training tools designed to enhance clinician proficiency and patient safety. The rising prevalence of cardiovascular diseases is a primary driver of the interventional cardiology devices industry growth. Sedentary lifestyles, poor dietary habits, and increasing rates of obesity and diabetes have led to a global surge in coronary artery disease and other cardiac conditions. This growing disease burden has increased the demand for timely and effective interventions, boosting the adoption of stents, catheters, and other interventional tools.In October 2024, the CDC reported that heart disease continues to be the top cause of death in the U.S., responsible for more than 919,000 deaths in 2023, or roughly one-third of all fatalities. A person dies from cardiovascular disease every 34 seconds, and around 5% of adults are affected by coronary artery disease. According to the research report "Global Interventional Cardiology Devices Market Outlook, 2031," published by Bonafide Research, the Global Interventional Cardiology Devices market was valued at more than USD 20.95 Billion in 2025, and expected to reach a market size of more than USD 30.79 Billion by 2031 with the CAGR of 6.80% from 2026-2031. Manufacturers are actively expanding their product portfolios through continuous upgrades and the introduction of next-generation interventional tools. Innovations include improved stent platforms, next-gen drug delivery systems, robotic-assisted catheterization labs, and enhanced guidewire technologies. This focus on iterative improvements is aimed at addressing unmet clinical needs such as complex lesion management, reduced restenosis rates, and improved patient recovery times. Companies are also investing in platform-based ecosystems that integrate diagnostics, navigation, and therapeutic capabilities. Technological innovations, including enhanced balloon catheters and drug-eluting systems, are improving clinical outcomes and reducing procedure times, thus encouraging adoption by healthcare providers. Increasing investment in healthcare infrastructure and growing patient preference for less invasive treatment alternatives further support market expansion. Advances in balloon catheter materials and design, such as improved flexibility, trackability, and inflation precision, have enhanced procedural safety and effectiveness. The segment benefits from broad clinical acceptance as a first-line treatment for coronary artery disease, supported by continuous improvements in balloon technology to address restenosis and complex lesions.
to Download this information in a PDF
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleMarket Dynamic
Market Drivers • Increasing Prevalence of Cardiovascular Diseases: One of the key drivers of the global interventional cardiology devices market is the rising incidence of cardiovascular diseases worldwide. Factors such as aging populations, sedentary lifestyles, unhealthy dietary habits, obesity, smoking, and diabetes have significantly increased the number of patients suffering from coronary artery disease and related heart conditions. As a result, the demand for minimally invasive procedures such as angioplasty and stent implantation has grown steadily. Interventional cardiology devices provide effective treatment with shorter recovery times and reduced surgical risks compared to traditional open heart surgery, which further accelerates their adoption across hospitals and cardiac centers globally. • Continuous Technological Advancements: Technological innovation is another major driver in the global interventional cardiology devices market. The development of advanced drug eluting stents, bioresorbable scaffolds, improved catheter systems, and high resolution imaging technologies has enhanced procedural accuracy and patient outcomes. Modern devices are designed to treat complex lesions more safely and efficiently, encouraging physicians to adopt newer solutions. Additionally, integration of digital imaging and robotic assistance has improved precision and reduced complications, supporting market growth and expanding the scope of interventional cardiology procedures worldwide. Market Challenges • High Cost of Devices and Procedures: One of the primary challenges in the global interventional cardiology devices market is the high cost associated with advanced devices and interventional procedures. Sophisticated stents, imaging systems, and catheter based technologies require substantial investment from healthcare facilities. In developing and underfunded healthcare systems, budget limitations can restrict access to these advanced treatments. The overall cost burden on patients, particularly in regions with limited insurance coverage, can further limit widespread adoption and slow market expansion. • Stringent Regulatory: Strict regulatory requirements pose another significant challenge for manufacturers in the global interventional cardiology devices market. Companies must undergo extensive clinical testing, safety evaluations, and compliance checks before receiving product approval from regulatory authorities. These lengthy approval timelines increase development costs and delay market entry. Furthermore, any device malfunction or recall can damage brand reputation and create financial setbacks, making regulatory compliance a critical and demanding aspect of the industry. Market Trends • Growing Preference for Outpatient Procedures: A major trend shaping the global interventional cardiology devices market is the increasing shift toward minimally invasive and outpatient based procedures. Patients and healthcare providers prefer catheter based interventions that reduce hospital stays, lower complication rates, and enable faster recovery. Many procedures are now performed in specialized cardiac centers or ambulatory settings, driving demand for compact, efficient, and easy to use interventional devices that support quicker treatment cycles. • Integration of Advanced Digital Technologies: Another important trend in the global interventional cardiology devices market is the integration of advanced imaging systems and digital technologies. Techniques such as intravascular ultrasound and optical coherence tomography allow for precise visualization of blood vessels, improving procedural accuracy. The use of data analytics and artificial intelligence in treatment planning enhances decision making and workflow efficiency. These technological integrations are transforming interventional cardiology practices and contributing to improved patient outcomes globally.
Segmentation
| By product | Angioplasty Stents | |
| Catheters | ||
| Angioplasty Balloons | ||
| Plaque Modification Devices | ||
| Hemodynamic Flow Alteration Devices | ||
| Structural Heart Devices | ||
| Other Accessories | ||
| By Application | Coronary Interventions | |
| Peripheral Vascular Interventions | ||
| Others | ||
| By End User | Hospitals | |
| Ambulatory Surgical Centers (ASCs) | ||
| Specialty Clinics | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Russia | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| South America | Brazil | |
| Argentina | ||
| Colombia | ||
| MEA | United Arab Emirates | |
| Saudi Arabia | ||
| South Africa | ||
Angioplasty stents are the largest product segment in the global interventional cardiology devices market because they are the most widely used and clinically effective solution for treating coronary artery disease and restoring blood flow in blocked arteries. As cardiovascular diseases continue to rise due to aging populations sedentary lifestyles poor dietary habits diabetes hypertension and smoking the number of patients requiring percutaneous coronary intervention procedures has increased significantly across both developed and emerging economies. During angioplasty procedures stents are implanted to keep arteries open after balloon dilation thereby preventing vessel recoil and reducing the risk of restenosis which makes them an essential component of interventional cardiology practice. The clinical effectiveness of stents particularly drug eluting stents which release medication to prevent scar tissue formation has improved patient outcomes and lowered repeat procedure rates compared to earlier bare metal stents which has strengthened physician confidence and increased procedural volumes globally. Hospitals and cardiac centers routinely adopt angioplasty stents because they offer a minimally invasive alternative to coronary artery bypass surgery resulting in shorter hospital stays reduced recovery times lower complication risks and improved patient satisfaction which further drives demand within the interventional cardiology devices market. Additionally continuous technological advancements in stent design such as thinner struts improved biocompatible polymers enhanced radial strength and better deliverability through complex vascular anatomies have expanded their application even in challenging cases including small vessels bifurcation lesions and high risk patients. Coronary interventions are the largest application segment in the global interventional cardiology devices market because coronary artery disease is the most prevalent and life-threatening cardiovascular condition worldwide requiring frequent minimally invasive treatment procedures. Coronary artery disease occurs when plaque builds up in the arteries supplying blood to the heart, leading to reduced blood flow, chest pain, heart attacks, and potentially fatal complications if not treated promptly. The growing incidence of risk factors such as aging populations, sedentary lifestyles, obesity, diabetes, hypertension, high cholesterol levels, and smoking has significantly increased the number of patients diagnosed with coronary conditions, thereby driving demand for coronary interventional procedures. These procedures, including angioplasty and stent placement, are minimally invasive and offer rapid restoration of blood flow compared to traditional open heart bypass surgery, making them the preferred treatment option for both physicians and patients. The high procedural volume associated with coronary interventions contributes substantially to overall revenue generation in the interventional cardiology devices market because millions of percutaneous coronary intervention procedures are performed globally each year. Hospitals and cardiac centers are well equipped with specialized catheterization laboratories dedicated primarily to coronary treatments, further reinforcing the dominance of this application segment. Technological advancements such as drug eluting stents, advanced balloon catheters, guidewires, and intravascular imaging systems have enhanced procedural precision and long term patient outcomes, reducing restenosis rates and improving survival, which strengthens clinical confidence in coronary interventions. Additionally, strong reimbursement policies for coronary procedures in many developed healthcare systems support widespread adoption and ensure financial sustainability for providers. Ambulatory Surgical Centers are the largest end user segment in the global interventional cardiology devices market because they offer cost effective minimally invasive cardiac procedures with faster patient turnaround and lower operational burden compared to traditional hospital settings. Interventional cardiology procedures such as angioplasty stent implantation and diagnostic catheter based interventions are minimally invasive in nature and typically require shorter recovery times which makes them highly suitable for performance in specialized outpatient facilities like Ambulatory Surgical Centers. These centers are designed to deliver focused surgical and interventional services without the extensive infrastructure and overhead costs associated with large multispecialty hospitals which allows them to perform high volumes of standardized cardiac procedures at lower overall cost. As healthcare expenditures continue to rise globally payers and providers are actively seeking care settings that can maintain high quality outcomes while reducing hospitalization expenses and Ambulatory Surgical Centers meet this need by minimizing inpatient admissions shortening procedure times and enabling same day discharge for many cardiac patients. Patients also prefer these centers because they offer reduced waiting times streamlined administrative processes and a more personalized care experience compared to busy hospital environments. Technological advancements in interventional cardiology devices including improved catheter systems compact imaging equipment and user friendly monitoring technologies have further enabled the safe performance of complex coronary procedures in outpatient settings thereby expanding the range of interventions that can be handled within Ambulatory Surgical Centers.
to Download this information in a PDF
Market Regional Insights
North America is the largest region in the global interventional cardiology devices market because of its high prevalence of cardiovascular diseases advanced healthcare infrastructure strong reimbursement systems and rapid adoption of innovative cardiac technologies. The region particularly the United States and Canada experiences a high burden of cardiovascular diseases including coronary artery disease heart attacks and peripheral vascular disorders driven by aging populations sedentary lifestyles obesity diabetes and hypertension which significantly increases the number of patients requiring minimally invasive cardiac interventions. This substantial patient pool directly fuels consistent demand for angioplasty stents catheters guidewires balloons and advanced imaging systems used in interventional cardiology procedures. In addition to disease prevalence North America benefits from a highly developed healthcare infrastructure comprising well equipped hospitals specialized cardiac centers and ambulatory surgical centers with advanced catheterization laboratories capable of performing complex coronary and peripheral interventions. The presence of skilled cardiologists and interventional specialists supported by continuous professional training ensures high procedural volumes and clinical expertise which further strengthens device utilization across the region. Strong reimbursement frameworks provided through private insurance government funded programs and structured healthcare coverage systems enable patients to access high cost interventional procedures with financial support reducing out of pocket burden and encouraging timely treatment adoption. This reimbursement stability provides manufacturers with predictable revenue streams and incentivizes hospitals to invest in premium and next generation devices.
to Download this information in a PDF
Key Development
• December 2025: the FDA cleared Vesalio’s enVast coronary mechanical thrombectomy system, introducing a stent-based approach for removing large coronary clots during primary PCI. The device, featuring proprietary Drop Zone technology, aims to improve clot capture and patient outcomes, marking Vesalio’s first regulatory approval in both the U.S. and Europe. • December 2025: SCAI and CRT announced a partnership to advance interventional cardiology through joint education, advocacy, and research initiatives. The collaboration will include discounted CRT event registration for SCAI members, coordinated legislative activities, and development of registries and clinical trials to enhance physician training and patient care. • September 2025: Interventional Medical Device Solutions (IMDS) began direct U.S. operations, naming Jason Bottiglieri as president. The shift from Biotronik distribution aims to enhance support and speed for complex percutaneous coronary interventions, providing physicians with direct access to IMDS’s PCI device portfolio. • May 2025: Boston Scientific announced collaborations with Philips and Siemens to integrate its iLab Ultrasound Imaging System with their interventional X-ray platforms. These integrations aim to enhance intravascular imaging capabilities within cath labs, offering improved workflow and imaging accuracy. • September 2024: Uppsala University launched a flexible stent to reduce complications in coronary artery surgery. The Infinity-Swedeheart study, involving 2,400 patients from 20 Swedish hospitals, compared this new stent to the conventional Resolute Onyx stent. This innovation has the potential to improve patient recovery and long-term outcomes in cardiac surgery. • May 2024: Abbott launched the XIENCE Sierra Everolimus Eluting Coronary Stent System in India, enhancing treatment options for patients with blocked coronary arteries. This latest generation stent offers improved safety for complex cases and is part of Abbott's ongoing efforts to advance the angioplasty procedure, a minimally invasive method to restore blood flow to the heart using stents.
Companies Mentioned
- Johnson & Johnson,
- Abbott Laboratories
- Medtronic plc
- Stryker corporation
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Terumo Corporation
- Vapotherm Inc.
- Dragerwerk AG & Co. KGaA
- Edwards Lifesciences Corporation
- Cook Group Incorporated
- AngioDynamics, Inc.
- Merit Medical Systems, Inc.
- MicroPort Scientific Corporation
- Cordis Corporation
- Biosensors International Group, Ltd.
- Asahi Intecc Co., Ltd.
- OrbusNeich Medical Group Holdings Ltd
- Integer Holdings Corporation
- Alvimedica
Table of Contents
- 1. Executive Summary
- 2. Market Dynamics
- 2.1. Market Drivers & Opportunities
- 2.2. Market Restraints & Challenges
- 2.3. Market Trends
- 2.4. Supply chain Analysis
- 2.5. Policy & Regulatory Framework
- 2.6. Industry Experts Views
- 3. Research Methodology
- 3.1. Secondary Research
- 3.2. Primary Data Collection
- 3.3. Market Formation & Validation
- 3.4. Report Writing, Quality Check & Delivery
- 4. Market Structure
- 4.1. Market Considerate
- 4.2. Assumptions
- 4.3. Limitations
- 4.4. Abbreviations
- 4.5. Sources
- 4.6. Definitions
- 5. Economic /Demographic Snapshot
- 6. Global Interventional Cardiology Devices Market Outlook
- 6.1. Market Size By Value
- 6.2. Market Share By Region
- 6.3. Market Size and Forecast, By Geography
- 6.4. Market Size and Forecast, By product
- 6.5. Market Size and Forecast, By Application
- 6.6. Market Size and Forecast, By End User
- 7. North America Interventional Cardiology Devices Market Outlook
- 7.1. Market Size By Value
- 7.2. Market Share By Country
- 7.3. Market Size and Forecast, By product
- 7.4. Market Size and Forecast, By Application
- 7.5. Market Size and Forecast, By End User
- 7.6. United States Interventional Cardiology Devices Market Outlook
- 7.6.1. Market Size by Value
- 7.6.2. Market Size and Forecast By product
- 7.6.3. Market Size and Forecast By Application
- 7.6.4. Market Size and Forecast By End User
- 7.7. Canada Interventional Cardiology Devices Market Outlook
- 7.7.1. Market Size by Value
- 7.7.2. Market Size and Forecast By product
- 7.7.3. Market Size and Forecast By Application
- 7.7.4. Market Size and Forecast By End User
- 7.8. Mexico Interventional Cardiology Devices Market Outlook
- 7.8.1. Market Size by Value
- 7.8.2. Market Size and Forecast By product
- 7.8.3. Market Size and Forecast By Application
- 7.8.4. Market Size and Forecast By End User
- 8. Europe Interventional Cardiology Devices Market Outlook
- 8.1. Market Size By Value
- 8.2. Market Share By Country
- 8.3. Market Size and Forecast, By product
- 8.4. Market Size and Forecast, By Application
- 8.5. Market Size and Forecast, By End User
- 8.6. Germany Interventional Cardiology Devices Market Outlook
- 8.6.1. Market Size by Value
- 8.6.2. Market Size and Forecast By product
- 8.6.3. Market Size and Forecast By Application
- 8.6.4. Market Size and Forecast By End User
- 8.7. United Kingdom (UK) Interventional Cardiology Devices Market Outlook
- 8.7.1. Market Size by Value
- 8.7.2. Market Size and Forecast By product
- 8.7.3. Market Size and Forecast By Application
- 8.7.4. Market Size and Forecast By End User
- 8.8. France Interventional Cardiology Devices Market Outlook
- 8.8.1. Market Size by Value
- 8.8.2. Market Size and Forecast By product
- 8.8.3. Market Size and Forecast By Application
- 8.8.4. Market Size and Forecast By End User
- 8.9. Italy Interventional Cardiology Devices Market Outlook
- 8.9.1. Market Size by Value
- 8.9.2. Market Size and Forecast By product
- 8.9.3. Market Size and Forecast By Application
- 8.9.4. Market Size and Forecast By End User
- 8.10. Spain Interventional Cardiology Devices Market Outlook
- 8.10.1. Market Size by Value
- 8.10.2. Market Size and Forecast By product
- 8.10.3. Market Size and Forecast By Application
- 8.10.4. Market Size and Forecast By End User
- 8.11. Russia Interventional Cardiology Devices Market Outlook
- 8.11.1. Market Size by Value
- 8.11.2. Market Size and Forecast By product
- 8.11.3. Market Size and Forecast By Application
- 8.11.4. Market Size and Forecast By End User
- 9. Asia-Pacific Interventional Cardiology Devices Market Outlook
- 9.1. Market Size By Value
- 9.2. Market Share By Country
- 9.3. Market Size and Forecast, By product
- 9.4. Market Size and Forecast, By Application
- 9.5. Market Size and Forecast, By End User
- 9.6. China Interventional Cardiology Devices Market Outlook
- 9.6.1. Market Size by Value
- 9.6.2. Market Size and Forecast By product
- 9.6.3. Market Size and Forecast By Application
- 9.6.4. Market Size and Forecast By End User
- 9.7. Japan Interventional Cardiology Devices Market Outlook
- 9.7.1. Market Size by Value
- 9.7.2. Market Size and Forecast By product
- 9.7.3. Market Size and Forecast By Application
- 9.7.4. Market Size and Forecast By End User
- 9.8. India Interventional Cardiology Devices Market Outlook
- 9.8.1. Market Size by Value
- 9.8.2. Market Size and Forecast By product
- 9.8.3. Market Size and Forecast By Application
- 9.8.4. Market Size and Forecast By End User
- 9.9. Australia Interventional Cardiology Devices Market Outlook
- 9.9.1. Market Size by Value
- 9.9.2. Market Size and Forecast By product
- 9.9.3. Market Size and Forecast By Application
- 9.9.4. Market Size and Forecast By End User
- 9.10. South Korea Interventional Cardiology Devices Market Outlook
- 9.10.1. Market Size by Value
- 9.10.2. Market Size and Forecast By product
- 9.10.3. Market Size and Forecast By Application
- 9.10.4. Market Size and Forecast By End User
- 10. South America Interventional Cardiology Devices Market Outlook
- 10.1. Market Size By Value
- 10.2. Market Share By Country
- 10.3. Market Size and Forecast, By product
- 10.4. Market Size and Forecast, By Application
- 10.5. Market Size and Forecast, By End User
- 10.6. Brazil Interventional Cardiology Devices Market Outlook
- 10.6.1. Market Size by Value
- 10.6.2. Market Size and Forecast By product
- 10.6.3. Market Size and Forecast By Application
- 10.6.4. Market Size and Forecast By End User
- 10.7. Argentina Interventional Cardiology Devices Market Outlook
- 10.7.1. Market Size by Value
- 10.7.2. Market Size and Forecast By product
- 10.7.3. Market Size and Forecast By Application
- 10.7.4. Market Size and Forecast By End User
- 10.8. Colombia Interventional Cardiology Devices Market Outlook
- 10.8.1. Market Size by Value
- 10.8.2. Market Size and Forecast By product
- 10.8.3. Market Size and Forecast By Application
- 10.8.4. Market Size and Forecast By End User
- 11. Middle East & Africa Interventional Cardiology Devices Market Outlook
- 11.1. Market Size By Value
- 11.2. Market Share By Country
- 11.3. Market Size and Forecast, By product
- 11.4. Market Size and Forecast, By Application
- 11.5. Market Size and Forecast, By End User
- 11.6. United Arab Emirates (UAE) Interventional Cardiology Devices Market Outlook
- 11.6.1. Market Size by Value
- 11.6.2. Market Size and Forecast By product
- 11.6.3. Market Size and Forecast By Application
- 11.6.4. Market Size and Forecast By End User
- 11.7. Saudi Arabia Interventional Cardiology Devices Market Outlook
- 11.7.1. Market Size by Value
- 11.7.2. Market Size and Forecast By product
- 11.7.3. Market Size and Forecast By Application
- 11.7.4. Market Size and Forecast By End User
- 11.8. South Africa Interventional Cardiology Devices Market Outlook
- 11.8.1. Market Size by Value
- 11.8.2. Market Size and Forecast By product
- 11.8.3. Market Size and Forecast By Application
- 11.8.4. Market Size and Forecast By End User
- 12. Competitive Landscape
- 12.1. Competitive Dashboard
- 12.2. Business Strategies Adopted by Key Players
- 12.3. Key Players Market Share Insights and Analysis, 2025
- 12.4. Key Players Market Positioning Matrix
- 12.5. Porter's Five Forces
- 12.6. Company Profile
- 12.6.1. Abbott Laboratories
- 12.6.1.1. Company Snapshot
- 12.6.1.2. Company Overview
- 12.6.1.3. Financial Highlights
- 12.6.1.4. Geographic Insights
- 12.6.1.5. Business Segment & Performance
- 12.6.1.6. Product Portfolio
- 12.6.1.7. Key Executives
- 12.6.1.8. Strategic Moves & Developments
- 12.6.2. Boston Scientific Corporation
- 12.6.3. Medtronic plc
- 12.6.4. Edwards Lifesciences Corporation
- 12.6.5. Terumo Corporation
- 12.6.6. B. Braun Melsungen SE
- 12.6.7. Teleflex Incorporated
- 12.6.8. MicroPort Scientific Corporation
- 12.6.9. Cordis Corporation
- 12.6.10. Merit Medical Systems, Inc
- 12.6.11. Biosensors International Group, Ltd.
- 12.6.12. Asahi Intecc Co., Ltd.
- 12.6.13. OrbusNeich Medical Group Holdings Ltd
- 12.6.14. Cook Group Incorporated
- 12.6.15. AngioDynamics, Inc.
- 12.6.16. Stryker Corporation
- 12.6.17. Getinge AB
- 12.6.18. Integer Holdings Corporation
- 12.6.19. Johnson & Johnson
- 12.6.20. Alvimedica
- 13. Strategic Recommendations
- 14. Annexure
- 14.1. FAQ`s
- 14.2. Notes
- 15. Disclaimer
Table 3: Top 10 Counties Economic Snapshot 2024
Table 4: Economic Snapshot of Other Prominent Countries 2022
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: Global Interventional Cardiology Devices Market Size and Forecast, By Geography (2020 to 2031F) (In USD Billion)
Table 7: Global Interventional Cardiology Devices Market Size and Forecast, By product (2020 to 2031F) (In USD Billion)
Table 8: Global Interventional Cardiology Devices Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 9: Global Interventional Cardiology Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
Table 10: North America Interventional Cardiology Devices Market Size and Forecast, By product (2020 to 2031F) (In USD Billion)
Table 11: North America Interventional Cardiology Devices Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 12: North America Interventional Cardiology Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
Table 13: United States Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 14: United States Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 15: United States Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 16: Canada Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 17: Canada Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 18: Canada Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 19: Mexico Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 20: Mexico Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 21: Mexico Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 22: Europe Interventional Cardiology Devices Market Size and Forecast, By product (2020 to 2031F) (In USD Billion)
Table 23: Europe Interventional Cardiology Devices Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 24: Europe Interventional Cardiology Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
Table 25: Germany Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 26: Germnay Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 27: Germany Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 28: United Kingdom (UK) Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 29: United Kingdom(UK) Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 30: United Kingdom (UK) Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 31: France Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 32: France Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 33: France Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 34: Italy Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 35: Itay Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 36: Italy Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 37: Spain Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 38: Spain Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 39: Spain Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 40: Russia Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 41: Russia Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 42: Russia Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 43: Asia-Pacific Interventional Cardiology Devices Market Size and Forecast, By product (2020 to 2031F) (In USD Billion)
Table 44: Asia-Pacific Interventional Cardiology Devices Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 45: Asia-Pacific Interventional Cardiology Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
Table 46: China Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 47: China Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 48: China Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 49: Japan Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 50: Japan Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 51: Japan Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 52: India Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 53: India Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 54: India Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 55: Australia Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 56: Australia Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 57: Australia Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 58: South Korea Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 59: South Korea Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 60: South Korea Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 61: South America Interventional Cardiology Devices Market Size and Forecast, By product (2020 to 2031F) (In USD Billion)
Table 62: South America Interventional Cardiology Devices Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 63: South America Interventional Cardiology Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
Table 64: Brazil Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 65: Brazil Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 66: Brazil Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 67: Argentina Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 68: Argentina Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 69: Argentina Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 70: Colombia Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 71: Colmbia Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 72: Colombia Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 73: Middle East & Africa Interventional Cardiology Devices Market Size and Forecast, By product (2020 to 2031F) (In USD Billion)
Table 74: Middle East & Africa Interventional Cardiology Devices Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 75: Middle East & Africa Interventional Cardiology Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
Table 76: United Arab Emirates(UAE) Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 77: United Arab Emirates(UAE) Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 78: United Arab Emirates (UAE) Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 79: Saudi Arabia Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 80: Saudi Arabia Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 81: Saudi Arabia Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 82: South Africa Interventional Cardiology Devices Market Size and Forecast By product (2020 to 2031F) (In USD Billion)
Table 83: South Africa Interventional Cardiology Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 84: South Africa Interventional Cardiology Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 85: Competitive Dashboard of top 5 players, 2025
Table 86: Key Players Market Share Insights and Analysis for Interventional Cardiology Devices Market 2025
Figure 2: Market attractiveness Index, By Region 2031F
Figure 3: Market attractiveness Index, By Segment 2031F
Figure 4: Global Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 5: Global Interventional Cardiology Devices Market Share By Region (2025)
Figure 6: North America Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 7: North America Interventional Cardiology Devices Market Share By Country (2025)
Figure 8: US Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 9: Canada Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 10: Mexico Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 11: Europe Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 12: Europe Interventional Cardiology Devices Market Share By Country (2025)
Figure 13: Germany Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 14: United Kingdom (UK) Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 15: France Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 16: Italy Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 17: Spain Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 18: Russia Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 19: Asia-Pacific Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 20: Asia-Pacific Interventional Cardiology Devices Market Share By Country (2025)
Figure 21: China Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 22: Japan Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 23: India Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 24: Australia Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 25: South Korea Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 26: South America Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 27: South America Interventional Cardiology Devices Market Share By Country (2025)
Figure 28: Brazil Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 29: Argentina Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 30: Colombia Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 31: Middle East & Africa Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 32: Middle East & Africa Interventional Cardiology Devices Market Share By Country (2025)
Figure 33: United Arab Emirates (UAE) Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 34: Saudi Arabia Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 35: South Africa Interventional Cardiology Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 36: Porter's Five Forces of Global Interventional Cardiology Devices Market
Market Research FAQs
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (09 May, 2026)
- Notify To Team (09 May, 2026)
- Report updation (10 May, 2026)
- Report Quality Check (10 May, 2026)
- Report Dispatch (11 May, 2026)
- Hard Copy
Recently Viewed Products
Global Interventional Cardiology Devices Market Outlook, 2031
We are friendly and approachable, give us a call.